The Searle Company Limited Stock price

Equities

SEARL

PK0061701014

Pharmaceuticals

End-of-day quote Pakistan S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
52.98 PKR +0.21% Intraday chart for The Searle Company Limited +0.36% +2.91%
Sales 2024 * 44.08B 159M Sales 2025 * 50.94B 183M Capitalization 20.67B 74.4M
Net income 2024 * 1.22B 4.39M Net income 2025 * 2.88B 10.38M EV / Sales 2024 * 0.99 x
Net Debt 2024 * 22.97B 82.71M Net Debt 2025 * 22.21B 79.96M EV / Sales 2025 * 0.84 x
P/E ratio 2024 *
20.5 x
P/E ratio 2025 *
9.39 x
Employees 2,716
Yield 2024 *
-
Yield 2025 *
-
Free-Float 59.07%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.21%
1 week+0.36%
Current month+2.24%
1 month+2.77%
3 months+0.90%
6 months+50.55%
Current year+2.91%
More quotes
1 week
51.50
Extreme 51.5
55.26
1 month
49.50
Extreme 49.5
56.68
Current year
43.03
Extreme 43.03
60.05
1 year
34.22
Extreme 34.22
64.09
3 years
34.22
Extreme 34.22
163.78
5 years
34.22
Extreme 34.22
178.46
10 years
27.58
Extreme 27.5845
315.61
More quotes
Managers TitleAgeSince
Chief Executive Officer - 07-12-31
Director of Finance/CFO - 14-10-22
Chief Tech/Sci/R&D Officer - 15-12-31
Members of the board TitleAgeSince
Chief Executive Officer - 07-12-31
Director/Board Member 60 -
Director/Board Member - 21-02-25
More insiders
Date Price Change Volume
24-03-28 52.98 +0.21% 2,352,639
24-03-27 52.87 -1.42% 2,236,912
24-03-26 53.63 -1.99% 3,941,911
24-03-25 54.72 +4.47% 12,179,540
24-03-22 52.38 -0.78% 1,415,487

End-of-day quote Pakistan S.E., March 27, 2024

More quotes
The Searle Company Limited is a Pakistan-based company, which is engaged in the manufacture of pharmaceuticals and other consumer products. The Company’s product categories include pharmaceutical, biopharmaceutical, nutraceutical, nutrition, consumer, and medical devices and disposables. The Company's product portfolio in the pharmaceutical range includes therapeutic areas, such as cardiovascular, respiratory care, gastroenterology, pain management, central nervous system (CNS), ortho care, neuropsychiatry, probiotics, antibiotics, and nutritional care. Its pharmaceutical products include Analgesic & Muscle-Relaxant, Anti-Allergy & Anti-Tussive, Anti-Anemic, Anti-Chelating, Anti-infective, Anti-Neoplastic, Anti-Thrombotic, Cardiovascular, Endocrinology & Metabolism. It also focuses on specialty generic branded portfolios and targeting differentiated products. Its subsidiaries include IBL HealthCare Limited, Searle Pharmaceuticals (Private) Limited, and others.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
52.98 PKR
Average target price
65 PKR
Spread / Average Target
+22.69%
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock The Searle Company Limited - Pakistan S.E.